Merck seeks to develop novel T-cell engager therapies with TriTAC platform: GlobalData
The deal includes the novel HPN-217 and HPN-328 compounds, which are currently undergoing Phase II clinical trials for various…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Phase 3 trial data confirm efficacy and safety profile of R21/Matrix-M malaria vaccine in African…
Investigators immunised over 4800 young children in a trial in Burkina Faso, Kenya, Mali and Tanzania and found on average 78 per…
Lupin gets US FDA nod for Dronedarone Tablets, USP
They are indicated to reduce the risk of hospitalisation for atrial fibrillation (AF) in patients in sinus rhythm with a history…
Drug price controls and emphasis on preventive care top solutions to address healthcare inflation:…
Inflation in healthcare refers to the persistent increase in the cost of medical goods and services over time. This phenomenon is…
Glenmark partners with Pfizer to launch Abrocitinib in India
When launched in India, it will be co-marketed under the brand names JABRYUS and CIBINQO by Glenmark and Pfizer respectively
AstraZeneca and Sanofi Beyfortus to dominate RSV market in China: GlobalData
In 2017, Sanofi entered into a collaboration agreement with MedImmune (AstraZeneca) to jointly develop and commercialise Beyfortus
Jubilant Pharma to sell its 25.8 per cent stake in Sofie Biosciences for $139.43 mn
Of this, $113.63 million is expected to be received upon completion of the merger while receipt of balance sum of $25.8 million is…
Glenmark and Ichnos launch Ichnos Glenmark Innovation to accelerate new drug discovery in cancer…
The newly formed IGI features a pipeline of three innovative oncology molecules targeting multiple myeloma, acute myeloid leukemia…
Zydus launches Rexigo, oral once-a-day pill to treat advanced prostate cancer
Relugolix is reportedly the only oral option of ADT drugs known as gonadotropin releasing hormone (GnRH) analogues
Orchid Pharma gets EMA approval for Exblifep
Exblifep has received EMA's recommendation for marketing authorization for use in treatment of complicated urinary tract…
Moderna leads development of mRNA vaccines in infectious diseases: GlobalData
Moderna has Phase III pipeline candidates in four different indications (COVID-19, influenza, RSV, and cytomegalovirus) and is…
Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg
Gabapentin is indicated for the management of Postherpetic Neuraligia (PHN)
STEER appoints TN Hari as Executive Chairman
Hari will set the strategic direction for STEER’s Engineering, Life Sciences and Materials businesses and oversee its…
Jiangsu Alphamab, 3D Medicines and Glenmark sign license pact for KN035 (Envafolimab)
Glenmark will be responsible for further developing, registering, and commercialising Envafolimab in India, Asia Pacific, Middle…
48 per cent of healthcare, pharma cos set to integrate first-Gen AI solution within next year: EY…
28 per cent surveyed have implemented their first GenAI solution, 60 per cent believe Gen AI will have a significant impact on the…
Siemens Healthineers, IISc launch laboratory for AI in precision medicine
The CDS collaborative laboratory will develop open-source AI-based tools to automate the segmentation of pathological findings in…
Venus Remedies gets GMP certification from Libya
This GMP certification has added to the company's portfolio of international approvals from 25 regulators
SII joins CEPI global network to boost production of affordable outbreak vaccines
CEPI is investing up to $30 million to expand the company’s existing capabilities and support rapid development of outbreak…
Lupin gets tentative US FDA approval for Rivaroxaban Tablets USP
This product will be manufactured at Lupin’s Pithampur facility in India
World’s first malaria vaccine rolled out in Cameroon
The vaccine, designed to be administered to young children in four doses from around five months of age, acts against P.…